Expertise in
7
conditions

Jordi T. Serra-Pueyo

Denmark Hill, 
London, ENG, GB 
Expertise in
7
conditions
Denmark Hill, 
London, ENG, GB 

Overview

Jordi Serra-Pueyo practices practicing medicine in London, United Kingdom.

Serra-Pueyo is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses Gastric Dysmotility, Gastroparesis, Indigestion, Thrombectomy, and Lung Transplant.

They are actively involved in clinical research, co-authoring 146 peer reviewed articles and participating in 2 clinical trials.

Locations

Denmark Hill, London, ENG, United Kingdom
Other Locations
UCL Queen Square Institute of Neurology
London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
Enrollment Status: Completed
Publish Date: September 22, 2023
Intervention Type: Drug
Study Drugs: Iberogast®, Iberogast® N
Study Phase: Phase 4
A Phase II, Multicentre, Randomised, Double-blind, Placebo Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
A Phase II, Multicentre, Randomised, Double-blind, Placebo Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

146 Total Publications

PPI-Refractory GERD in Systemic Sclerosis Is Driven by Distinct Esophageal and Gastric Motility Abnormalities.
PPI-Refractory GERD in Systemic Sclerosis Is Driven by Distinct Esophageal and Gastric Motility Abnormalities.
Journal: medRxiv : the preprint server for health sciences
Published: May 01, 2026

Frequently Asked Questions about Jordi T. Serra-Pueyo

Is Jordi T. Serra-Pueyo a top-rated expert for Gastric Dysmotility?

MediFind is an objective health platform that identifies experts based on real-world data. Jordi T. Serra-Pueyo is classified as an Distinguished expert for Gastric Dysmotility, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jordi T. Serra-Pueyo participate in research or clinical trials?

Yes. Jordi T. Serra-Pueyo has published 146 articles and abstracts on conditions like Gastric Dysmotility. You can view a list of Jordi T. Serra-Pueyo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Serra-Pueyo's expertise for a condition
ConditionClose
    View All 32 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile